ICON plc (ICLR)
ICLR trades on Nasdaq in Health Care, Biotechnology: Commercial Physical & Biological Resarch. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$164.34
-0.04% on the day
Market cap
$12.6B
Large cap
Revenue · 2025
$8.3B
+0.8% on 2024
Net income · 2025
$229.3M
2.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ICLR on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch |
| Country | Ireland |
| IPO year | 1998 |
| SEC CIK | 0001060955 |
| SEC industry code | Services-Commercial Physical & Biological Research |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $8.3B |
| Net income | $229.3M |
| Operating income | $442.8M |
| Net margin | 2.8% |
| Operating margin | 5.4% |
| Revenue growth | +0.8% |
| Cash | $647.3M |
| Total assets | $16.3B |
| P/E (computed) | 54.9× |
| P/S (computed) | 1.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2024-05-02 |
| Latest annual report | 20-F | 2026-05-27 |
| Latest quarterly / interim | 6-K | 2026-10-08 |
Source: SEC EDGAR submissions feed, 829 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +2.8% |
| 1 month | -2.2% |
| 3 months | -0.8% |
| Year to date | -7.5% |
| 1 year | -9.4% |
| From 52-week high | -16.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Commercial Physical & Biological Resarch
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CRL | Charles River Laboratories International Inc. | $299.02 | -0.94% | $14.3B |
| MEDP | Medpace Holdings Inc. | $609.89 | -1.64% | $17.0B |
| INCY | Incyte Corp. | $108.62 | -2.46% | $22.0B |
| IQV | IQVIA Holdings Inc. | $260.68 | -0.58% | $42.9B |
| ABSI | Absci Corporation | $9.10 | -5.89% | $1.6B |
| OABI | OmniAb Inc. | $4.70 | -1.47% | $683.3M |
| NRC | NRC Health | $20.17 | -1.18% | $446.2M |
| MXCT | MaxCyte Inc. | $0.9643 | -3.08% | $99.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier